Alexithymia prevalence among patients with chronic dermatological diseases in a tertiary hospital, Saudi Arabia.

Hamad Alfahaad
{"title":"Alexithymia prevalence among patients with chronic dermatological diseases in a tertiary hospital, Saudi Arabia.","authors":"Hamad Alfahaad","doi":"10.5114/ada.2023.129944","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Alexithymia is a psychological condition characterized by difficulty in identifying and expressing one's emotions, and it has been associated with several physical and mental health disorders.</p><p><strong>Aim: </strong>To determine the prevalence of alexithymia among patients with a range of chronic dermatological diseases in a Saudi public hospital.</p><p><strong>Material and methods: </strong>477 patients who were over 14 years old and affected by one of the following chronic skin conditions: psoriasis, atopic dermatitis, acne, alopecia areata, vitiligo, hidradenitis suppurativa, pemphigus vulgaris, chronic urticaria were included in this study. Alexithymia was assessed in these patients by using the Toronto Alexithymia Scale (TAS) which is a widely used, reliable and valid measure of this construct.</p><p><strong>Results: </strong>Prevalence of alexithymia among chronic dermatological disease patients ranges from 14.8% to 71.4%, with an overall occurrence of 43%. The highest prevalence of alexithymia was found in hidradenitis suppurativa (71.4%) and the lowest in acne (14.8%). Overall, the alexithymia cases were predominantly male (51.7%). The distribution of male and female cases with alexithymia varied among patients with different types of chronic skin diseases, with the highest male prevalence in psoriasis (58.7%) and the highest female prevalence in pemphigus vulgaris (66.7%).</p><p><strong>Conclusions: </strong>Alexithymia is prevalent among patients with chronic dermatological diseases and dermatologists' awareness of how to identify and address alexithymia among their patients can play a vital role in improving treatment adherence and outcomes.</p>","PeriodicalId":7212,"journal":{"name":"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646714/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ada.2023.129944","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Alexithymia is a psychological condition characterized by difficulty in identifying and expressing one's emotions, and it has been associated with several physical and mental health disorders.

Aim: To determine the prevalence of alexithymia among patients with a range of chronic dermatological diseases in a Saudi public hospital.

Material and methods: 477 patients who were over 14 years old and affected by one of the following chronic skin conditions: psoriasis, atopic dermatitis, acne, alopecia areata, vitiligo, hidradenitis suppurativa, pemphigus vulgaris, chronic urticaria were included in this study. Alexithymia was assessed in these patients by using the Toronto Alexithymia Scale (TAS) which is a widely used, reliable and valid measure of this construct.

Results: Prevalence of alexithymia among chronic dermatological disease patients ranges from 14.8% to 71.4%, with an overall occurrence of 43%. The highest prevalence of alexithymia was found in hidradenitis suppurativa (71.4%) and the lowest in acne (14.8%). Overall, the alexithymia cases were predominantly male (51.7%). The distribution of male and female cases with alexithymia varied among patients with different types of chronic skin diseases, with the highest male prevalence in psoriasis (58.7%) and the highest female prevalence in pemphigus vulgaris (66.7%).

Conclusions: Alexithymia is prevalent among patients with chronic dermatological diseases and dermatologists' awareness of how to identify and address alexithymia among their patients can play a vital role in improving treatment adherence and outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
沙特阿拉伯某三级医院慢性皮肤病患者述情障碍患病率
述情障碍是一种以难以识别和表达个人情绪为特征的心理疾病,与多种身心健康障碍有关。目的:确定述情障碍的患病率患者与一系列慢性皮肤病在沙特公立医院。材料与方法:本研究纳入477例年龄在14岁以上的慢性皮肤病患者:银屑病、特应性皮炎、痤疮、斑秃、白癜风、化脓性汗腺炎、寻常型天疱疮、慢性荨麻疹。使用多伦多述情量表(TAS)对这些患者进行述情评估,TAS是一种广泛使用、可靠和有效的量表。结果:慢性皮肤病患者述情障碍患病率为14.8% ~ 71.4%,总发生率为43%。化脓性汗腺炎中述情障碍患病率最高(71.4%),痤疮中最低(14.8%)。总体而言,述情障碍病例以男性为主(51.7%)。不同类型慢性皮肤病患者述情障碍的男女分布不同,男性以银屑病患病率最高(58.7%),女性以寻常型天疱疮患病率最高(66.7%)。结论:述情障碍在慢性皮肤病患者中普遍存在,皮肤科医生对如何识别和解决患者述情障碍的认识对提高治疗依从性和疗效起着至关重要的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review. Clinical efficacy and metabolomic analysis of ozone major autohemotherapy for the treatment of herpes zoster. The efficacy of metformin for the treatment of psoriasis: a meta-analysis study. Influence of adalimumab on interleukin 12/23 signalling pathways in human keratinocytes treated with lipopolysaccharide A. Micronutrient deficiency with skin and systemic symptoms: a case report of acrodermatitis enteropathica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1